Home Insights Ashfield Advisory launches its Advisory Ecosystem in response to market demand

Ashfield Advisory launches its Advisory Ecosystem in response to market demand

3 mins read
26 January 2021

Today, Ashfield Advisory, a business unit of Ashfield, part of UDG Healthcare, plc., outlines its new Advisory Ecosystem Model. The Ashfield Advisory businesses – Vynamic, Putnam, STEM Healthcare and SmartAnalyst – combine their expertise to provide specialist, yet integrated services to customers spanning insight, strategy, action and evaluation.

Ashfield has built the Advisory platform through selective acquisition and strong organic growth. The carefully curated ecosystem of healthcare-focused advisory businesses is perfectly positioned to offer niche, boutique consulting to its customers, through the existing business models and brands.

Now, Ashfield Advisory can also offer a connected suite of services by bringing the best of these businesses together, offering integrated service lines, and connected thinking across the commercialisation continuum.

“Our customers’ challenges require the best solutions. Through our existing Advisory businesses, they have enjoyed the highest quality service and output for many years. But we also get requests for broader, connected service offerings, or enquiries about our capabilities across our businesses”, commented Colin Stanley, Global President, Ashfield Advisory.

“Our Advisory Ecosystem model allows customers to work through the existing relationships they have with our businesses, but still access our broader capabilities. We provide them with a connected, data driven, insightful and actionable solution, as well as access to the best consultants in the best boutique firms. Frankly that drives value, and differentiates us clearly from the big Consulting Firms, or CROs where life science is not a speciality, or drug development revenues are the priority.”

Ashfield Advisory’s growth ambitions are not limited to the current business set.

There is clear aspiration to continue along the current trajectory of both organic and inorganic growth. Stanley continues: “We have created Ashfield Advisory as a platform for further scale and diversification. We already see significant interest from our customers in acquiring connected services. That feedback helps us to identify further M&A opportunity, such as today’s acquisition of PHMR which will form part of the Putnam Associates business, building out our market access capabilities and our footprint in Europe and Japan.

“It also aligns neatly with our fundamental strategy of investment in our existing Advisory businesses and to create an environment where they can prosper and enjoy sustainable, but expedited growth.”

The Ashfield Advisory companies collectively offer an advanced strategic consulting experience but individually provide four distinct offerings in the health arena; STEM Healthcare focuses on brand management effectiveness and benchmarking, Vynamic is a management consulting firm focused on organisational change prioritising culture, SmartAnalyst provides strategic consulting with a focus on science and data and Putnam Associates is a strategic consulting firm focused on market access and commercial strategy.